Jim Beitel
Corporate Officer/Principal bei FATE THERAPEUTICS, INC.
Profil
Jim Beitel is currently the Senior Vice President-Corporate Development at Fate Therapeutics, Inc. He previously worked as the Director & Director-Business Development at Zacharon Pharmaceuticals, Inc. and as the Vice President-Corporate Development & Operations at Avanir Pharmaceuticals, Inc. Mr. Beitel received his undergraduate degree from the University of Kansas and his MBA from Harvard Business School.
Aktive Positionen von Jim Beitel
| Unternehmen | Position | Beginn |
|---|---|---|
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 14.09.2017 |
Ehemalige bekannte Positionen von Jim Beitel
| Unternehmen | Position | Ende |
|---|---|---|
Zacharon Pharmaceuticals, Inc.
 Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Director/Board Member | 01.08.2011 |
| AVANIR PHARMACEUTICALS INC | Chief Operating Officer | 01.08.2007 |
Ausbildung von Jim Beitel
| University of Kansas | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Health Technology |
